Michelle Liang, M.D.
Dr. Michelle C. Liang is an Associate Professor of Ophthalmology at the Tufts University School of Medicine and a vitreoretinal surgeon at the New England Eye Center in Boston, MA. She graduated with honors from Johns Hopkins University with a degree in Biology and earned her medical degree from the University at Buffalo School of Medicine and Biomedical Sciences. She performed her residency in ophthalmology at the New England Eye Center at Tufts Medical Center and went on to complete a highly-regarded 2-year vitreoretinal surgery fellowship at the New England Eye Center and Ophthalmic Consultants of Boston.
Dr. Liang has authored numerous scientific papers and book chapters and has presented at several regional and national meetings. She is also co-editor of the book “Anti-VEGF Use in Ophthalmology.” She treats all medical and surgical conditions of the retina and vitreous, including macular degeneration, central serous chorioretinopathy, vitreomacular disorders, diabetic retinopathy, retinal vascular occlusions, retinal detachment, and cataract complications, and she implanted the first Argus II retinal prosthesis for the surgical management of advanced retinitis pigmentosa in New England. She is also involved with resident and fellow teaching at the New England Eye Center and is currently co-director of the vitreoretinal surgery combined fellowship with Ophthalmic Consultants of Boston. Her research interests include retinal imaging and new therapies for macular degeneration, diabetic macular edema, and other retinal diseases. Dr. Liang is a board-certified member of the American Board of Ophthalmology and a member of the American Academy of Ophthalmology, American Society of Retinal Specialists, Vit-Buckle Society, and Retina Society.
All medical and surgical conditions of the retina and vitreous, including macular degeneration, macular diseases, vitreomacular disorders, diabetic retinopathy, retinal vascular disorders, retinal detachment, ocular trauma, and cataract complications.
Retinal imaging and new therapies for macular degeneration, diabetic macular edema, and other retinal diseases. She was the primary investigator for the Argus II Retinal Prosthesis Post-Approval Study and is currently investigating if gene therapy has the potential to slow the progression of geographic atrophy in dry age-related macular degeneration.